Back to search

National and Kapodistrian University of Athens

Μελέτη του συμπλόκου αποικοδόμησης της β-κατενίνης σε σποραδικά και κληρονομικά διηθητικά καρκινώματα μαστού

Abstract

dc:description

Breast cancer is the most common malignancy occurring in women. So far, despite the progress made in identifying and treating breast cancer, mortality remains high. Today, research focuses on finding molecular prognostic markers that will contribute to better treatment of these patients. Among the biomarkers studied, are those associated with signal transduction pathways. These pathways are associated with survival, proliferation and migration of cancer cells. The signaling pathway Wnt / beta-catenin has been considered as a central regulator of the translation of proteins involved in controlling proliferation, growth, migration and survival of cancer cells and thus participates in the carcinogenesis and progression of breast cancer.Wnt proteins constitute a large family of glycoproteins that bind to Frizzled receptors. The Wnt signaling pathway regulates at least three different cascades, but the best studied is that of beta-catenin. It has been shown that abnormalities of this pathway lead to various human diseases, such as the formation of tumors and genetic bone disorders.According to the generally accepted model for this pathway, when Wnt is not active in cells, a complex consisting of the proteins CKIa (casein kinase Ia), GSK-3β (glycogen synthase kinase-3β), APC (adenomatous polyposis coli) and Axin is formed. This complex phosphorylates beta-catenin which is subsequently degraded in the cytoplasm.The existence of mutations in exon 3 of beta-catenin gene is associated with an aggressive phenotype in some cancer types such as prostate, endometrial and hepatocellular carcinomas. In breast cancer, however, mutations in exon 3 of the gene of beta-catenin are rare or absent.The aim of this study was to investigate the expression pattern of the proteins participating in the destruction complex of beta-catenin AXIN, and GSK-3β in 232 invasive breast carcinomas (154 sporadic and 78 familial) and the existence of mutations in exons 1 and 2 of the beta-catenin gene in 124 cases. The results of these markers were statistically analyzed in order to investigate their association with a) Classical clinicopathological parameters (age, menopausal status, tumor size, histological type, histological and nuclear grade, stage and hormone receptors), b) Overall and disease-free patients’ survival, c) Novel biological markers. Based on the correlations obtained we estimate the possible involvement of these proteins, and mutations of beta-catenin gene, in aggressiveness and prognosis of breast cancer.Our material consisted pf 232 primary invasive breast carcinomas of which 154 were sporadic and 78 familial, 188 ductal and 44 lobular, from 232 female patients aged 25 to 87 years. The average follow-up period for overall survival was 161 months. Eighty-two patients experienced relapses, with an average follow-up for 161 months. In order to investigate the expression pattern of the proteins we applied the three-steps immunohistochemical method of the avidin - biotin - peroxidase complex, and to study the existence of mutations in exons 1 and 2 of the beta-catenin gene we used the polymerase chain reaction (PCR) method in 124 cases of invasive breast carcinomas. The statistical evaluation of the results and individual correlations was performed using univariate (chi-square test and log rank test) and multivariate (Cox's hazard regression model) analysis.Results: Axin protein was detected in the cytoplasm and the nucleus of cancer cells in 159 (68.5%) and 101 (43.5%) cases, respectively, as well as in the stromal fibroblasts in 159 (68.5%) cases. Concurrent cancerous and stromal immunostaining was observed in 121 (52.2%) cases. The conserved cytoplasmic protein expression was positively associated with lymph node status (p = 0.022), with the expression of HER-2 and GSK-3β proteins (p = 0.020 and p = 0.027, respectively) and inversely with the expression of Ki-67 and topoisomerase IIa (p = 0.011 and p = 0.031, respectively) proteins’ expression. Positive cytoplasmic staining of Axin was positively associated with stage (p = 0.028) and its nuclear expression showed a positive correlation with tumor size (p = 0.025). The localization of the protein in stromal fibroblasts showed a parallel association with lymph node status (p = 0.048) and the expression of HER-2 protein (p <0.001). Simultaneous immunodetection of Axin in the cytoplasm of cancer cells and in stromal fibroblasts was inversely correlated with the bcl-2 protein expression (p = 0.016). Neither cancerous nor stromal expression of the protein was found to exert any influence on overall and disease-free survival in the total of patients. However, in the subgroup of patients with invasive lobular breast cancer, conserved cytoplasmic localization of Axin was found to exert an unfavorable impact on patients’ overall survival (p = 0.024), in the univariate statistical analysis.The protein kinase GSK-3β was detected in the cytoplasm of cancer cells at a rate of 57.1% (133/233 cases) and in stromal fibroblasts in 28.7% (67/233 cases). The cytoplasmic localization of the protein was positively associated with the expression of HER-2 and Akt proteins (p = 0.045 and p = 0.039, respectively) and inversely correlated with the expression of PTEN protein (p = 0.011). The stromal expression of GSK-3β was positively correlated with the expression of caspase-3 (p = 0.020) and inversely with the expression of ER (p = 0.035), Ki-67 and Akt (p = 0.015 and p = 0.046, respectively) proteins’ expression. Neither cancerous nor stromal expression was associated with any of the classical clinicopathological parameters of breast cancer, and was not found to have any impact on overall and disease-free survival in the total of patients. However, in the subgroup of patients with HER-2 - negative breast carcinomas, cytoplasmic expression of GSK-3β was found to exert an unfavorable impact on disease-free survival (p = 0.021), in univariate statistical analysis.In exon 1 of the beta-catenin gene, mutations were detected at a rate of 13.7% (17/124 cases), which consisted of base substitutions in different nucleotide positions. By using the BLAST algorithm, we observed a perfect match (100% homology) between the first 7 base pairs of the internal ribosome entry segments (IRES) of the 5’ untranslated region of c-myc gene and nucleotide positions 111-117 of exon 1. Concerning exon 2, mutations were detected in18.5% (23/124 cases), which consisted of base substitutions in different nucleotide positions. The vast majority of these mutations (22/23, 95.6% of cases) were detected near nucleotide position 405, which lies within the second intron of the gene. Among these mutations, we observed a frequent change in the sequence from GAATTG to GAATAG, resulting in the creation of an AG dinucleotide, which could potentially serve as an alternative splice acceptor site. The other mutation was detected in the translation start codon (ATG).In conclusion, the results concerning Axin and GSK-3β proteins suggest that the degradation complex of beta-catenin is dysfunctional in the invasive breast carcinomas used in this study. Furthermore, it appears that beta-catenin itself is negatively regulated at the gene level, further supporting the hypothesis that the oncogenic pathway Wnt / beta-catenin is activated in the material of our study.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Theohari, Irini
  • Θεοχάρη, Ειρήνη

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/31774

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Theohari, Irini; Θεοχάρη, Ειρήνη. Μελέτη του συμπλόκου αποικοδόμησης της β-κατενίνης σε σποραδικά και κληρονομικά διηθητικά καρκινώματα μαστού. National and Kapodistrian University of Athens, 2012. http://hdl.handle.net/10442/hedi/31774